Equity Overview
Price & Market Data
Price: $0.0451
Daily Change: +$0.0318 / 70.51%
Daily Range: $0.0451 - $0.0451
Market Cap: $31,648,048
Daily Volume: 5,000
Performance Metrics
1 Week: 275.8%
1 Month: 275.8%
3 Months: -9.80%
6 Months: -49.89%
1 Year: 244.3%
YTD: %
Details
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.